UT scientist Erik Groot Jebbink wants to use microbubbles for improving the treatment of liver cancer. Pre-injecting microbubbles to see their route towards the tumor could be key to improve the precision of delivering injected cell-killing radioactive particles at the tumor site.
Using a newly developed nano-size biosensor, UT scientists Pepijn Beekman and Dilu Mathew can detect small tumor cell fragments in blood at very low concentrations. These so-called tumor-derived extracellular vesicles (tdEVs) are effective biomarkers for the presence and activity of a tumor.
‘Everyone has focused on treating COVID-19, not its collateral damage - which includes delay in cancer diagnosis and treatment,’ says UT professor Maarten IJzerman. He and UT alumnus Koen Degeling have developed a model to show the impact of the pandemic on cancer patients.
For many people, the word ‘cryogenics’ prompts sci-fi movie flashbacks and images of human bodies being frozen just to be brought back to life hundreds of years later. While that might not be possible, cryogenic engineering relates to many useful and often groundbreaking applications. UT scientist Srinivas Vanapalli, who leads the only cryogenics research group in the Netherlands, is working on some of them. Including a method to ‘freeze and destroy’ tumor cells.